Understanding adverse events related to perioperative immunotherapy: A primer for thoracic surgeons Editorial


Author: Jones, D. R.
Title: Understanding adverse events related to perioperative immunotherapy: A primer for thoracic surgeons
Keywords: event free survival; overall survival; drug tolerability; monotherapy; treatment duration; neoadjuvant therapy; cancer staging; disease association; cancer immunotherapy; editorial; perioperative period; correlational study; non small cell lung cancer; randomized controlled trial (topic); adverse event; phase 3 clinical trial (topic); nivolumab; human; thoracic surgeon
Journal Title: Thoracic Cancer
Volume: 12
Issue: 17
ISSN: 1759-7706
Publisher: Wiley-Blackwell Publishing Asia  
Date Published: 2021-09-01
Start Page: 2291
End Page: 2292
Language: English
DOI: 10.1111/1759-7714.14097
PUBMED: 34378865
PROVIDER: scopus
PMCID: PMC8410568
DOI/URL:
Notes: Editorial -- Export Date: 1 October 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Randolph Jones
    417 Jones